LEIDEN, Netherlands & CAMBRIDGE, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated…
VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF…
STOUGHTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to…
Recognizing the healing power of art, RBC’s gift will help bring beauty to the halls of the MUHC while preserving…
BOSTON, April 20, 2023 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory…
Fourth major clinical trial to select PharmAla Biotech as supplier in AustraliaVANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) --…
Study Demonstrates BVA Provides More Accurate Congestion Measurement in Challenging Patient Populations Oak Ridge, TN, April 20, 2023 (GLOBE NEWSWIRE)…
- Presentations to cover updated clinical and preclinical data on pipeline candidates in Company’s thyroid eye disease program - -…
LAS VEGAS, NV, April 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the intention…
Preclinical data from LBIO-115 exon 51 program demonstrate superior levels of exon-skipping that result in high levels of dystrophin restoration…